TurnCare Announces New Real-World Evidence at ISPOR 2026 Highlighting the Clinical and Economic Burden of Hospital-Acquired Pressure Injuries
TurnCare Announces New Real-World Evidence at ISPOR 2026 Highlighting the Clinical and Economic Burden of Hospital-Acquired Pressure Injuries
TurnCare, Inc. Announces New Leadership Appointments to Advance Company’s Transition to Commercial Organization
TurnCare, Inc. Announces John F. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors
Please do not include any personal information in your message to us.